Skip to main content
Recall Canary
Levothyroxine Sodium Tablets 300 mcg
← Back to all recalls
DRUG RECALLMODERATE

Levothyroxine Sodium Tablets 300 mcg

Accord Healthcare is recalling 300 mcg Levothyroxine Sodium Tablets due to subpotency.

What to do

Contact your healthcare provider or pharmacist to discuss alternative treatment options and return the affected medication to your pharmacy.

Recalled
Listed
Updated
Recall No.
D-0656-2026
Agency
FDA
Firm
ACCORD HEALTHCARE, INC.
Recall ID
99194
Status
ONGOING

Recall at a glance

Quantity recalled
6432 bottles

Why it was recalled

Accord Healthcare is recalling Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg) due to the product being subpotent. This recall affects the 90-count bottle presentation.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Levothyroxine Sodium Tablets, USP

Lot code
2026
Strength
300 mcg
NDC / UPC
NDC 16729-458-15

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Drug Potency recalls

Other recent recalls from ACCORD HEALTHCARE, INC.

All recalls from ACCORD HEALTHCARE, INC.

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-07-01 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification